Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07815093

Multimodal Artificial Intelligence for Non-Invasive Colorectal Cancer Screening Based on Holographic Biology

The purpose of this study is to propose a non-invasive screening method by integrating holographic biological theory and artificial intelligence technology. A colorectal cancer risk assessment model will be constructed by analyzing multimodal data including facial features, tongue image characteristics and exhaled gas. The hypothesis of this study is that the model can attain both sensitivity and specificity of 80%.This study will enroll patients aged 18-80 years scheduled to undergo colonoscopy. All participants shall provide informed consent and sign the informed consent form. Patients will be excluded if they have severe cardiac, cerebral, pulmonary or renal dysfunction, or psychiatric disorders precluding colonoscopy, have a history of gastrointestinal surgery, or have taken bismuth agents or other staining medications. Based on estimates from existing literature, the training set will require tongue images, facial images, exhaled gas analysis results and colonoscopic diagnoses from 5000 patients, and the test set will require such data from 6000 patients.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients aged 18-80 years scheduled to undergo colonoscopy.
  • All patients provide informed consent and sign the informed consent form.

Exclusion criteria

  • Patients with severe cardiac, cerebral, pulmonary or renal dysfunction, or psychiatric disorders that prevent colonoscopy;
  • Patients with a history of gastrointestinal surgery;
  • Patients taking bismuth agents or other staining medications.

Treatment and study plan

Multimodal non-invasive detection for colorectal cancer

Other

Collection of facial images, tongue images and exhaled gas data from participants. No therapeutic intervention is performed. The collected multimodal data will be used to build an artificial intelligence-based colorectal cancer risk assessment model.

Primary outcomes

  1. Presence of colonic polyps and colorectal cancer.

    Time frame: At the time of enrollment and colonoscopy examination

Sponsors and collaborators

Lead sponsor

Xiuli Zuo

Other

Registry information

Official study title

Multimodal Artificial Intelligence for Non-Invasive Colorectal Cancer Screening Based on Holographic Biology.

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Sep 11, 2026
Registry last updated
Sep 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.